From the Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom (D.J.P., S.G.W., R.M.M., E.F., B.D.K.).
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (M.J.M., H.J.C., L.S., A.T., M.S.-K.).
Circ Res. 2019 Feb 15;124(4):553-563. doi: 10.1161/CIRCRESAHA.118.313250.
Familial recurrence studies provide strong evidence for a genetic component to the predisposition to sporadic, nonsyndromic Tetralogy of Fallot (TOF), the most common cyanotic congenital heart disease phenotype. Rare genetic variants have been identified as important contributors to the risk of congenital heart disease, but relatively small numbers of TOF cases have been studied to date.
We used whole exome sequencing to assess the prevalence of unique, deleterious variants in the largest cohort of nonsyndromic TOF patients reported to date.
Eight hundred twenty-nine TOF patients underwent whole exome sequencing. The presence of unique, deleterious variants was determined; defined by their absence in the Genome Aggregation Database and a scaled combined annotation-dependent depletion score of ≥20. The clustering of variants in 2 genes, NOTCH1 and FLT4, surpassed thresholds for genome-wide significance (assigned as P<5×10) after correction for multiple comparisons. NOTCH1 was most frequently found to harbor unique, deleterious variants. Thirty-one changes were observed in 37 probands (4.5%; 95% CI, 3.2%-6.1%) and included 7 loss-of-function variants 22 missense variants and 2 in-frame indels. Sanger sequencing of the unaffected parents of 7 cases identified 5 de novo variants. Three NOTCH1 variants (p.G200R, p.C607Y, and p.N1875S) were subjected to functional evaluation, and 2 showed a reduction in Jagged1-induced NOTCH signaling. FLT4 variants were found in 2.4% (95% CI, 1.6%-3.8%) of TOF patients, with 21 patients harboring 22 unique, deleterious variants. The variants identified were distinct to those that cause the congenital lymphoedema syndrome Milroy disease. In addition to NOTCH1, FLT4 and the well-established TOF gene, TBX1, we identified potential association with variants in several other candidates, including RYR1, ZFPM1, CAMTA2, DLX6, and PCM1.
The NOTCH1 locus is the most frequent site of genetic variants predisposing to nonsyndromic TOF, followed by FLT4. Together, variants in these genes are found in almost 7% of TOF patients.
家族复发研究为散发性非综合征性法洛四联症(TOF)易感性的遗传因素提供了强有力的证据,TOF 是最常见的发绀性先天性心脏病表型。已经确定罕见的遗传变异是先天性心脏病风险的重要因素,但迄今为止,研究 TOF 病例的数量相对较少。
我们使用全外显子组测序来评估迄今为止报告的最大一组非综合征性 TOF 患者中独特的、有害变异的流行率。
829 例 TOF 患者接受了全外显子组测序。通过其在基因组聚集数据库中的缺失以及标准化的综合注释依赖性耗竭评分≥20 来确定独特的、有害变异的存在。在经过多重比较校正后,2 个基因(NOTCH1 和 FLT4)中的变异聚类超过了全基因组显著水平(赋值为 P<5×10)。NOTCH1 最常携带独特的、有害的变异。在 37 个先证者中观察到 31 种变化(4.5%;95%CI,3.2%-6.1%),包括 7 种失活变异、22 种错义变异和 2 种框内插入缺失。7 例病例中未受影响父母的 Sanger 测序鉴定出 5 种新生变异。3 种 NOTCH1 变异(p.G200R、p.C607Y 和 p.N1875S)进行了功能评估,其中 2 种显示 Jagged1 诱导的 NOTCH 信号降低。TOF 患者中有 2.4%(95%CI,1.6%-3.8%)发现 FLT4 变异,21 例患者携带 22 种独特的、有害的变异。鉴定出的变异与导致先天性淋巴水肿综合征米尔罗伊病的变异不同。除了 NOTCH1、FLT4 和已确立的 TOF 基因 TBX1,我们还在几个其他候选基因中发现了与变异相关的潜在关联,包括 RYR1、ZFPM1、CAMTA2、DLX6 和 PCM1。
NOTCH1 基因座是导致非综合征性 TOF 的遗传变异最常见的位置,其次是 FLT4。这些基因中的变异在近 7%的 TOF 患者中发现。